Ripple Therapeutics Corporation is an active federal corporation (corporation number 11752901). Its business number is 760459073. It was incorporated on Nov 22, 2019 under the Canada Business Corporations Act and its registered office is in Toronto, Ontario. Its annual returns are up to date, most recently for 2025. It has eight directors on record.
Corporate details
- Corporation number
- 11752901
- Business number
- 760459073
- Status
- Active
- Governing law
- Canada Business Corporations Act
- Incorporated
- Nov 22, 2019
- Corporation type
- Non-distributing corporation with 50 or fewer shareholdersAs declared in its 2025 annual return.
- Registered office
- 101 College Street, Suite 300
MaRS Centre, South Tower
Toronto ON M5G 1L7 - Number of directors
- At least 1, at most 10As the articles allow.
Annual filings
- Anniversary date
- Nov 22The date of incorporation, amalgamation or continuance.
- Annual filing period
- Nov 22 to Jan 21 each year
- Last annual meeting
- Dec 30, 2024
| Year | Annual return | Annual meeting |
|---|---|---|
| 2026 | Not yet due Due from Nov 22, 2026 | |
| 2025 | Filed | Dec 30, 2024 |
| 2024 | Filed | Dec 30, 2024 |
The last annual return filed, and each year since.
Directors
Loading the directors from the federal record...
Federal grants and contributions
14 agreements since 2020, worth $1,731,172 in all.
| Department | Program | Value | Starts |
|---|---|---|---|
| National Research Council Canada | Youth Employment - Material Engineer | $30,000 | Jul 1, 2026 |
| National Research Council Canada | Dry AMD manufacturing development and optimization | $150,000 | Apr 1, 2026 |
| National Research Council Canada | Drug Product Development Engineer Support | $25,000 | Apr 16, 2025 |
| National Research Council Canada | R&D Engineering support | $30,000 | Sep 12, 2024 |
| Innovation, Science and Economic Development Canada | FR-35211 | $15,000 | Aug 30, 2024 |
| National Research Council Canada | RTC-PG Sustained Release Prostaglandins | $300,000 | Apr 1, 2024 |
| National Research Council Canada | Lab support | $30,000 | Aug 1, 2023 |
| National Research Council Canada | Sustained release form targeting wet age-related macular degeneration | $22,984 | Sep 1, 2022 |
| National Research Council Canada | Associate research scientist | $30,000 | Apr 1, 2022 |
| National Research Council Canada | IBE-814 IVT Diabetic Macular Edema and Retinal Vein Occlusion | $810,564 | Jan 1, 2022 |
As each federal department publishes them (proactive disclosure). A value is the agreement's total as last amended; the money may be paid over several years. The 10 most recent are shown. Search every federal grant.
Names
| Name | Form | In use since |
|---|---|---|
| Ripple Therapeutics Corporation | Name | Nov 22, 2019 |
Filings and certificates
| What | Date |
|---|---|
| Articles amended | Nov 25, 2020 |
| Incorporated | Nov 22, 2019 |
Registered in a province as well? Find provincial registrations(opens in a new tab). Something wrong or out of date? Request a correction.